Launched by the Medicines and Healthcare products Regulatory Agency (the MHRA), the seventh annual #MedSafetyWeek is running until 13 November to encourage widespread public engagement and improve patient safety by reporting suspected side effects associated with medicines and adverse incidents involving medical devices.
Have you been prescribed an active topical treatment for psoriasis? Would you like to help researchers to understand how to best support people to use these treatments by taking a short online survey?
The second issue of PAPAA’s Pso Pscience review digest is now available to download. The digest is aimed at providing a brief look at some recent research developments in psoriasis and psoriatic arthritis.
Would you like to get involved with research or promote participation in an actvity? Whether you are a patient, working with patients or have an interest in research, you may wish to visit our new website opportunities section.
The University of Hertfordshire, Nutrition and Dietetics Department is exploring the role of diet in the management of psoriasis: Dietary behaviours, perceptions and self-reported skin outcomes of people with psoriasis
PAPAA has just published issue 55 of our popular Skin 'n' Bones Connection journal. You can get a copy on subscription or buy a copy from the PAPAA shop.
Psoriasis in Practice an online training programme for healthcare professionals has now been reaccredited by the Royal College of Nursing (RCN) Centre for Professional Accreditation.
Worth 10-study hours with a certificate issued on completion.
Updated inclusion criteria for weight and psoriasis research.
A project is being undertaken at King’s College London called Feelings, Emotions And Behaviours In Weight And Psoriasis. People living with psoriasis often describe weight management as a challenge. Several factors are likely to explain why managing weight alongside psoriasis can be difficult.
Have you considered supporting PAPAA as a good cause? People at PAPAA have been working since the early 1990s to raise awareness and support those affected by psoriasis and psoriatic arthritis.
People with mild to moderate plaque-type psoriasis are needed for a research study. You must be aged 18 to 65 years old and have a confirmed diagnosis for at least 6 months.